Gender differences in schizophrenia;Diferencias de género en la esquizofrenia

Revista de Psiquiatria de la Facultad de Medicina de Barcelona

Volumn 30, Issue 5, 2003, Pages 276-287

  Usall, Judith ^a  

^a Serveis de Salut Mental ^*  (Spain)

Author keywords

Estrogenic theory; Gender differences; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; ESTROGEN; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

AGRANULOCYTOSIS; CLINICAL TRIAL; COGNITION; DISEASE COURSE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG RESPONSE; DYSTONIA; EOSINOPHILIA; ESTROGEN ACTIVITY; EXTRAPYRAMIDAL SYMPTOM; FAMILIAL DISEASE; FEMALE; HUMAN; HYPERPROLACTINEMIA; IMAGING; INCIDENCE; MALE; MATERNAL DISEASE; NEGATIVE SYNDROME; NEUROPSYCHOLOGY; ONSET AGE; PREGNANCY COMPLICATION; PREVALENCE; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL INTERACTION; SYMPTOMATOLOGY; TARDIVE DYSKINESIA;

EID: 0345528030     PISSN: 02137429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Addington D, Addington J, Patten S. Gender and affect in schizophrenia. Can J Psychiatry 1996;41(5):265-8.
2. Albus M, Scherer J, Hueber S, Lechleruthner T, Kraus G, Zausinger S, Burkes S. The impact of familial loading gender differences in age at onset in schizophrenia. Acta Psychiatr Scand 1994;89:132-4.
3. Albus M, Hubmann W, Mohr F, Scherer J, Sobizack N, Franz U, Hetch S, Borrmann M, Wahlheim C. Are there gender differences in neuropsychological performance in patients with first episode schizophrenia? Schizophr Res 1997;28(1):39-50.
4. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 2003;60(6):565-71.
5. Alvir JMJ, Lieberman JA. Agranulocytosis: Incidence and risk factors. J Clin Psychiatry 1994;55,9(suppl B):137-8.
6. Andia AM, Zisook S, Heaton RK, Hesselink J, Jernigan T, Kuck J, Moranville J, Braff DL. Gender differences in schizophrenia. J Nerv Ment Dis 1995;183(8):522-8.
7. Andreasen NC, Ehrhardt JC, Swayze VW II, Alliger RJ, Yuh WT, Cohen G, Ziebell S. Magnetic resonance imaging of the brain in schizophrenia. The pathophisiologic significance of structural abnormalities. Arch Gen Psychiatry 1990;47(1):35-44.
8. Angermeyer MC, Goldstein JM, Kühn L. Gender differences in schizophrenia: Rehospitalization and community survival. Psy Chol Med 1989;19:365-82.
9. Angermeyer MC, Kühn L, Goldstein JM. Gender and the course of schizophrenia: differences in treated outcomes. Schizophr Bull 1990;16(2):293-307.
10. Bland RC, Orn H. Long term mental illness in Canada: an epidemiological perspective on schizophrenia and affective disorders. Can J Psychiatry 1984;29:242-6.
11. Bryant NL, Buchanan RW, Vladar K, Breier A, Rothman M. Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. Am J Psychiatry 1999;156:603-9.
12. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992;22(3):787-97.
13. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustement in chronic schizophrenia. Schizophr Bull 1982;8(3):470-84.
14. Cantor-Graae EmcNeil TF, Sjostrom K, Nordstrom LG, Rosenlund T. Obstetric complications and their relationshipto other etiological risk factors in schizophrenia. A case-control study. J Nerv Men Dis 1994;182(11):645-50.
15. Castle DJ, Wessely S, Murray RM. Sex and schizophrenia: effects of diagnostic stringency and associations with premorbid variables. Br J Psychiatry 1993;162:658-64.
16. Castle D, Sham P, Murray R. Differences in distribution of ages at onset in males and females with schizophrenia. Schizophr Res 1998;33(3):179-83.
17. Childers SE, Harding C. Gender, premorbid social functioning and long term outcome in DSM-III schizophrenia. Schizophr Bull 1990;16(2):309-16.
18. Cowell PE, Kostianovsky DJ, Gur RC, Turetsky BI, Gur RE. Sex differences in neuroanatomical and clinical correlations in schizophrenia. Am J Psychiatry 1996;153 (6):799-805.
19. Davis JA, Goldstein MJ, Nuechterlein. KH Gender differences in family attitudes about schizophrenia. Psychol Med 1996;26(4):689-96.
20. Di Paolo T. Modulation of brain dopaminetransmission by sex steroids. Rev Neurosci 1994;5(1):27-42.
21. Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess Ph, Woof K. Long-term course of hospitalization for schizophrenia: Part I. Risk for rehospitalization. Schizophr Bull 1992;18(2):217-28
22. Flaum M, Swayze VWII, O'Leary DS, Yuh WTC, Ehrhardt JC, Arndt SV, Andreasen NC.Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am J Psychiatry 1995:152:704-14.
23. Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: Relations to psychopathology and medication side effects. Am J Psychiatry 1992; 149:1189-94.
24. Goldberg TE, Gold JM, Torrey EF, Weinberger DR. Lack of sex differences in the neuropsychological performance in patients with schizophrenia. Am J Psychiatry 1995;152:883-8.
25. Goldstein JM, Link BG. Gender and the expression pf schizophrenia. J Psychiatr Res 1988;22:141-55.
26. Goldstein JM. Gender differences in the course of schizophrenia. Am J Psychiatry 1988;145(6):684-9.
27. Goldstein JM, Tsuang MT, Faraone SV. Gender and schizophrenia: implications for understanding the nature of the disorder Psychiatry Res 1989;28:243-53.
28. Goldstein JM, Santangelo SL, Simpson JC, Tsuang M. The role of gender in identifying subtypes of schizophrenia: a latent class analytic approach. Schizophr Bull 1990;16(2):263-76.
29. Goldstein JM, Faraone SV, Chen WJ, Tolomiczencko GS, Tsuang MT. Sex diferences in the familial transmission of schizophrenia. Br J Psychiatry 1990;156:819-26.
30. Goldstein JM, Faraone SV, Chen WJ, Tsuang MT. Gender and the familial risk for schizophrenia. Disentangling confounding factors. Schizophr Res 1992;7(2):135-40.
31. Goldstein JM, Seidman LJ, Santangelo S, Knapp P; Tsuang MT. Are schizophrenic men at higher risk for developmental deficits than schizophrenic women? implications for adult neuropsychological functions. J Psychiatr Res 1994;28:483-98.
32. Goldstein JM, Faraone SV, Chen WJ, Tsuang MT. Genetic heterogeneity may in part explain sex differences in the familial risk for schizophrenia. Biol Psychiatry 1995;38 (12):808-13.
33. Goldstein JM, Seidman LJ, Goodman JM, Koren D, Lee H, Weintraub S, Tsuang MT. Are there neuropsychological functions among patients with schizophrenia? Am J Psychiatry 1998;155(10):1358-64.
34. Goldstein JM, Cohen LS, Horton NJ, Lee H, Andersen S, Tohen M, Crawford A, Tollefson G. Sex differences in clinical response to olanzapine compared with haloperidol. Psychiatry Res 2002;110(1):27-37.
35. Gur RE, Gur RC. Gender differences in regional cerebral blood flow. Schizophr Bull 1990;16:247-54.
36. Gur RE, Mozley PD, Shtasel DL, Cannon TD, Gallacher F, Turetsky B, Grossman R, Gur RC. Clinical subtypes of schizophrenia: differences in brain and CSF volume. Am J Psychiatry 1994;151(3):343-50.
37. Gureje G. Gender and schizophrenia: age at onset and sociodemographic attributes. Acta Psychiatr Scan 1991;83:402-5.
38. Gureje O, Bamidele RW. Gender and schizophrenia: association with age at onset with antecedents, clinical and outcome feature. Aust N Z J Psychiatry 1998;32:415-23.
39. Haas GL, Glick ID, Clarkin JF, Spencer JH, Lewis AB. Gender and schizophrenia outcome: a clinical trial of an inpatient family intervention. Schizophr Bull 1990;16 (2):277-92.
40. Häfner H, Riecher-Rössler A, An Der Heiden W, Maurer K, Fätkenheuer B, Löffler W. Generating and testing a causal explanation of the gender difference in age at first onset schizophrenia. Psycol Med 1993;23:925-40.
41. Häfner H, Maurer K, Loffler W, an der Heiden W, Munk-Jorgensen P, Hambretch M, Riecher-Rossler A. The ABC Schizophrenia study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 1998;33(8):380-6.
42. Häfner H, An Der Heiden W, Behrens S, Gattaz WF, Hambretch M, Löffler W, y cols. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 1998;24(1):99-113.
43. Hambretch M, Riecher-Rössler A, Fätkenheuer B, Louzä MR, Häfner H. Higher morbidity risk for schizophrenia in males: Fact or fiction? Compr Psychiatry 1994;35 (1):39-49.
44. Hayashi N, Igarashi Y, Yamashina M, Suda K. Is there a gender difference in a factorial structure of the positive and negative syndrom scale. Psychopathology 2002; 35:28-35.
45. Heun R, Maier W. The role of obstetric complications in schizophrenia. J Nerv Ment Dis 1993;181(4):220-6.
46. Hien D, Haas G, Cook H. Gender differences in premorbid social adjustement and intimacy motivation in schizophrenia. Int J Clin Psychology 1998;54:35-48.
47. Hoff AL, Wieneke M, Faustman WO, Horon R, Sakuma M, Blankfeld H, Espinoza S, DeLisi LE. Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients. Am J Psychiatry 1998;155:1437-1439.
48. Hultman CM, Ohman A, Cnattingius S, Wieselgren I, Linström LH. Prenatal and neonatal risk factors for schizophrenia. Br J Psychiatry 1997;170:128-33.
49. Iacono WG, Beiser M. Are males more likely than females to develop schizophrenia? Am J Psichiatry 1992;149: 1070-4.
50. Kendler KS, Walsh D. Gender and schizophrenia. Results of an Epidemiologically-based Familiy Study. Br J Psychiatry 1995;167:184-92.
51. Kirov G, Jones PB, Harvey I, Lewis SW, Toone BK, Rifkin, y cols. Do obstetric complications cause the earlier age at onset in male than female schizophrenics? Schizophr Res 1996;20(1-2):117-24.
52. Kraepelin E. Psychiatrie, 4th Edition. Leipzig. Germany: Barth, 1893.
53. Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 1996;20:247-52.
54. Kulkarni J, Riedel A, de Castella AR, Fitzgerald PB, Rolfe TJ, Taffe J, Burger H. Estrogen-a potential treatment for schizophrenia. Schizophr Res 2001;48(1):137-44.
55. Kunugi H, Shinichiro N, Takei N, Saito K, Hayashi N, Kazamatsuri H. Schizophrenia folowing in utero exposure to the 1957 influenza epidemics in Japan. Am J Psychiatry 1995;152:450-2.
56. Labelle A, Light M, Dunbar F. Risperidone treatment of outpatients with schizophrenia: no evidence of sex differences in treatment response. Can J Psychiatry 2001;46(6):534-41.
57. Larsen TK, McGlashan TH, Johannessen JO, Vibe-Hansen L. First-episode schizophrenia: II. Premorbid patterns by gender. Schizophr Bull 1996;22(2):257-69.
58. Leung A, Leung P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand 2000;101:3-38.
59. Lewine RRJ. Sex differences in schizophrenia: timing or subtypes? Psychol Bull 1981;90:432-444.
60. Lewine RJ, Burbach D, Meltzer HY. Effect of diagnosic criteria on the ratio of male to female schizophrenic patients. Am J Psychiatry 1984;141:84-87.
61. Lewine RRJ, Gulley LR, Risch SC, Jewart R, Houpt JL. Sexual dimorphism, brain morphology, and schizophrenia. Schizophr Bull 1990;16:195-204.
62. Lewine RRJ, Seeman MV. Gender, brain and schizophrenia. En: Seeman MV, ed. Gender and psychopathology. Washington: American Psychiatric Press, 1995.
63. Lewine RRJ, Walker EF, Shurett R, Caudle J, Haden C. Sex difference in neuropsichological functioning among schizophrenic patients. Am J Psychiatry 1996;153: 1178-84.
64. Lewis S. Sex and schizophrenia: Vive la difference. Br J Psychiatry 1992;161:445-50.
65. Lindamer LA, Lohr JB, Harris MJ, McAdams LA, Jeste DV. Gender-related clinical differences in older patiens with schizophrenia. J Clin Psychiatry 1999;60(1):61-9.
66. Lindamer LA, Buse DC, Lohr JB, Jeste DV. Hormone replacement therapy in pstmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry 2001;49(1):47-51.
67. Linström E, von Knorring L. Symptoms in schizophrenic syndromes in relation to age, sex, duration of illness and number of previous hospitalizations. Acta Psychiatr Scand 1994;89:274-8.
68. Maier W, Lichtermann D, Minges J, Heun R, Halmayer J. The impact of gender and age at onset on the familial aggregation of schizophrenia. Eur Arch Psychiatry Clin Neurosci 1993;242(5):279-85.
69. McGlashan TH, Bardenstein KK. Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull 1990;16(2):319-29.
70. Malla AK, Tarhar J, Norman RMG, Assis L. Computed tomographic findings in schizophrenia: relation with symptom dimensions and sex differences. J Psychiatry Neurosci 1999;24(2):131-8.
71. Melkerssson KI, Hulting AL, Rane AJ. Dose requirement and prolactine elevation of antipsychotics in male and famale patients with schizophrenia or related psychoses. Br J Clin Pharmacol 2001;51(4):317-24.
72. Meltzer HY, Busch D, Fang V. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. Psychiatry Res 1983;9:271-83.
73. Moriarty PJ, Lieber D, Bennet A, White L, Parrella M, Harvey PD, Davis KL. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophr Bull 2001;27(1):103-13.
74. Mueser KT, Lewine S, Bellack AS, Douglas MS, Brady EU. Social skills training for acute psychiatric inpatients. Hosp Comm Psychiatry 1990;41:1249-51.
75. Nasser Eh, Walders N, Jenkins JH. The experience of schizophrenia: What's gender got to do with it? A critical review of the current status of research in schizophrenia. Schizophr Bull 2002;28(2):351-62.
76. Nopoulos P, Flaum M, Andreasen NC. Sex differences in brain morphology in schizophrenia. Am J Psychiatry 1997;154:1648-54.
77. O'Connell P, Woodruff PWR, Wright I, Jones P, Murray RM. Developmental insanity or dementia praecox: was the wrong concept adopted? Schizophr Res 1997;23:97-106.
78. Opjordsmoen S. Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatr Scand 1991;83:307-13.
79. Owen MJ, Lewis SW, Murray RM. Obstetric complications and schizophrenia: a computed tomography study. Psychol Med 1988;18(2):331-9.
80. Perlick D, Mattis S, Stastny P, Teresi J. Gender differences in cognition in schizophrenia. Schizophr Res 1992;8:69-73.
81. Perry PJ, Miller DD, Arnott SV, Cadoret RJ. Clozapine and norclozapine plasma concentrations and clinical response of treatment refractory schizophrenic patients. Am J Psychiatry 1991;148:231-5.
82. Pulver AE, Brown CH, Wolyniec P, McGrath J, Tam D, Adler L, Carpenter WT, Childs B. Schizophrenia: age at onset, gender and familial risk. Acta Psychiatr Scand 1990; 82(5):344-51.
83. Pulver AE, Liang KY. Estimating effects of proband characteristics on familial risk: II. The association between age at onset and familial risk in the Maryland schizophrenia sample. Genet Epidemiol 1991;8(5):339-50.
84. Raine A, Harrison GN, Reynolds GP, Sheard C, Cooper JE, Medley I. Structural and functional characteristics of the corpus callosum in schizophrenics, psychiatric controls, and normal controls. A magnetic resonance imaging and neuropsychological evaluation. Arch Gen Psychiatry 1990;47(11):1060-4.
85. Riecher-Rössler A, Hafner H, Dutsch-Stroebel M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994;20(1):203-14.
86. Riecher-Rösler A, Häfner H. Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta Psychiatr Scand 2000;102:58-62.
87. Ring N, Tantam D, Montague L, Newby D, Black D, Morris J. Gender differences in the incidence of definite schizophrenia and atypical psychosis-focus on negative symptoms of schizophrenia. Acta Psychiatr Scand 1991;84(6):489-496.
88. Salokangas RKR. Prognostic implications of the sex of schizophrenic patients. Br J Psychiatry 1983;142: 145-51.
89. Salokangas RK, Saarijarvi S, Taiminen T, Lehto H, Niemi H, Ahola V, y cols. Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 1997;23(1):55-60.
90. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R. Early manifestations and first contact incidence of schizophrenia in different cultures. Psych Medicine 1986;16:909-28.
91. Schaub A, Behrendt B, Brenner HD, Mueser KT, Liberman RP. Training schizophrenic patients to manage their symptoms: predictors of treatment response to the German version of the Symptom Management Module. Schizophr Res 1998;31:121-30.
92. Seeman MV. Neuroleptic prescriptions for men and women. Social Pharmacology 1989;3:219-36.
93. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990;16(2):185-94.
94. Seidman LJ, Goldstein JM, Goodman JM, Koren D, Turner WM, Faraone SV, Tsuang MT. Sex differences in olfactory identification and Wisconsin Card Sorting performance in schizophrenia: relationship to attention and verbal ability. Biol Psychiatry 1997;42:104-15.
95. Sellwood W, Tarrier N. Demographic factors associated with extreme non-compliance in schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1994;29:172-7.
96. Sham PC, O'Callaghan E, Takei N, Murray GK, Hare EH, Murray RM. Schizophrenia following prenatal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry 1992;160:461-6.
97. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Gur RC. Gender differences in the clinical expression of schizophrenia. Schizophr Res 1992;7:225-31.
98. Sichel DA, Cohen LS, Robertson LM, Ruttenberg A, Rosenbaum JF. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995;38: 814-8.
99. Smith TH, Hull JW, Anthony DT, Goodman M, Heydayat-Harris A, Felger T, y cols. Post-hospitalization treatment adherence of schizophrenic patients: gender differences in skill acquisition. Psychiatr Res 1997;69(2-3)123-9.
100. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J, Woerner M, Cooper T. Gender differences in onset of illness, treatment response, course and biological indexes in first episode schizophrenic patients. Am J Psychiatry 1995;152:698-703.
101. Szymanski S. Sex differences in schizophrenia. En: Jensvold MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and Women. Sex, gender and hormones. Washington, DC: American Psychiatric Press, 1996.
102. Szymanski S, Lieberman JA, Pollack S, Kane JM, Safferman AZ, Munne R, y cols. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biol Psychiatry 1996;39:249-54.
103. Takei N, Sham PC, O'Callaghan E, Murray GK, Glover G, Murray RM. Prenatal exposure to influenza and development of schizophrenia: Is the effect confined to females? Am J Psychiatry 1994;151:117-9.
104. Takei N, Van Os J, Murray RM. Maternal exposure to influenza and the risk of schizophrenia: a 22 year study from The Netherlands. J Psychiatr Res 1995;29:425-45.
105. Takei N, Mortensen PB, Klaening U, Murray RM; Sham PC, O'Callaghan E, Munk-Jorgensen P. Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark. Biol Psychiatry 1996; 40:817-24.
106. Test MA, Burke SS, Wallisch LS. Gender differences of young adults with schizophrenic disorders in community care. Schizophr Bull 1990;16(2):331-44.
107. Usall J, Ochoa S, Araya S, Gost A, Busquets E y grupo NEDES. Sintomatología y género en la esquizofrenia. Actas Esp Psiquiatr 2000;28(4):219-223.
108. Usall J, Araya S, Ochoa S, Busquets E, Gost A, Márquez M, and NEDES Group (Assessment Research Group in schizophrenia). Gender differences in a sample of schizophrenic outpatients. Compr Psychiatry 2001; 42(4):301-305.
109. Usall J, Haro JM, Ochoa S, Márquez M, Araya S, and NEDES Group (Assessment Research Group in schizophrenia). Influence of gender on social outcome in schizophrenia. Acta Psychiatr Scand 2002;106:337-342.
110. Vázquez-Barquero JL, Cuesta MJ, Herrera S, Lastra I, Herrán A, Dunn G. Cantabria first-episode schizophrenia study: three-year follow-up. British Journal of Psychiatry 1999;174:141-9.
111. Verdoux H, Bourgeois M. A comparative study of obstetric history in schizophrenics, bipolar patient and normal subjects. Schizophr Res 1993;9:67-9.
112. Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, y cols. Obstetric complications and age at onset in schizophrenia: An international collaborative meta-analysis of individual patient data. Am J Psychiatry 1997; 154(9):1220-7.
113. Waddington JL, Youssef HA. Evidence for a gender decline in the rate of schizophrenia in rural Ireland over a 50-year period. Brit J Psychiatry 1994;164:171-6.
114. Walker E, Bettes BA, Kain EL, Harvey P. Relationship of gender and marital status with symptomatology in psychotic patients. J Abnorm Psychol 1985;94:42-50.
115. Wyatt RJ, Alexander RC, Egan MF, Kirch DG. Schizophrenia, just the facts: What we know, how well do we know it? Schizophr Res 1988;1:3-18.
116. Yassa R, Jeste DV. Gender differences in tardive dyskinesia: A critical review of the literature. Schizophr Bull 1992; 18(4):701-15.
117. Yonkers KA, Kando JC, Cole JA, Blumenthal S Gender differences in pharmacokinetics and pharmacodynamics in psychotropic medication. Am J Psychiatry 1992;149:587-95.
118. Youseff HA, Kinsella A, Waddington JL. Evidence for geographical variations in the prevalence of schizophrenia in rural Ireland. Arch Gen Psychiatry 1991;48:254-8.